DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C0013146 | Drug abuse | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0079731 | B-Cell Lymphomas | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0018801 | Heart failure | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0025289 | Meningitis | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0006142 | Malignant neoplasm of breast | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0008479 | Chondrosarcoma | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0278878 | Adult Glioblastoma | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0026896 | Myasthenia Gravis | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0340569 | Internal Carotid Artery Stenosis | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0006826 | Malignant Neoplasms | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0018802 | Congestive heart failure | CDS2 | 8760 | CDP-diacylglycerol synthase 2 | O95674 |
C0015397 | Disorder of eye | CDS2 | 8760 | CDP-diacylglycerol synthase 2 | O95674 |
C0027651 | Neoplasms | CDS2 | 8760 | CDP-diacylglycerol synthase 2 | O95674 |
C0018801 | Heart failure | CDS2 | 8760 | CDP-diacylglycerol synthase 2 | O95674 |
C0026896 | Myasthenia Gravis | CDIPT | 10423 | CDP-diacylglycerol--inositol 3-phosphatidyltransferase | O14735 |
C2930619 | Sex Differentiation Disorders | CDIPT | 10423 | CDP-diacylglycerol--inositol 3-phosphatidyltransferase | O14735 |
C0019269 | Hermaphroditism | CDIPT | 10423 | CDP-diacylglycerol--inositol 3-phosphatidyltransferase | O14735 |
C0007131 | Non-Small Cell Lung Carcinoma | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
C0678222 | Breast Carcinoma | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
C0027651 | Neoplasms | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
C0006826 | Malignant Neoplasms | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
C0009402 | Colorectal Carcinoma | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
C0152013 | Adenocarcinoma of lung (disorder) | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
C0699790 | Colon Carcinoma | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
C0025202 | melanoma | CEACAM5 | 1048 | CEA cell adhesion molecule 5 | P06731 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024